期刊
MOLECULAR IMAGING AND BIOLOGY
卷 16, 期 6, 页码 854-864出版社
SPRINGER
DOI: 10.1007/s11307-014-0762-z
关键词
In vivo phage display; Kidney uptake; Protein reabsorption; Peptides; Radioimaging; Nanoparticles; Biological nanoparticles
资金
- Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development
- NIH/NCI [DHHS 1R21CA137239-01A1]
Clinical use of most radiolabeled targeting agents has been limited because of the uptake and retention in kidney and/or liver. We hypothesized that bacteriophage (phage) display could be exploited to select for peptide sequences with fast clearance and low kidney uptake with the added ability to redirect phage clearance away from the reticuloendothelial system towards the kidney possessing rapid kidney clearance. In vivo phage display was performed to identify peptides displayed on phage that were excreted rapidly into the urine of mice. A novel in vitro assay using kidney cells, developed to predict in vivo kidney retention, and in vivo pharmacokinetic analyses were performed to characterize selected peptides/phage clones. Forty-three renal clearance clones (RCC) were identified. In vivo mixing experiments and in vitro kidney cell assays identified RCC1-02 as the lead compound. In vivo analysis of fluorescently labeled phage clones demonstrated the ability of RCC1-02 peptide to redirect the biodistribution of the large phage particle towards excretion via the kidney. Pharmacokinetic analysis of [In-111]-radiolabeled peptides revealed that kidney retention of the control ErBB-2-avid peptide, [In-111]DOTA-KCCYSL, at 2-h postinjection was 5.7 +/- 0.7 %ID/g. In comparison, [In-111]DOTA-RCC1-02 had kidney retention values of 1.66 +/- 0.43 %ID/g, respectively. In vivo phage display can identify phage and corresponding peptides that rapidly clear the renal system. In the future, these peptides may be used to impart favorable pharmacokinetics onto a wide range of radioimaging or therapeutic macromolecules.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据